666
Participants
Start Date
September 18, 2019
Primary Completion Date
July 19, 2022
Study Completion Date
June 19, 2023
Dihydroartemisinin-piperaquine (DHA-PPQ)
Following physical examination, recruited women with more than 13 weeks of gestational age will receive IPTp-DHA-PPQ under supervision
Placebo Oral Tablet
Following physical examination, recruited women with more than 13 weeks of gestational age will receive IPTp-Placebo under supervision
Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné
Centro de Investigação em Saúde de Manhiça (CISM), Manhiça
Medicines for Malaria Venture
OTHER
Universität Tübingen
OTHER
Centre de Recherche Médicale de Lambaréné
OTHER
Medical University of Vienna
OTHER
Bernhard Nocht Institute for Tropical Medicine
OTHER_GOV
Centro de Investigação em Saúde de Manhiça
OTHER
Barcelona Institute for Global Health
OTHER